Human Immunodeficiency Virus Viral Suppression Being Impacted By Buprenorphine
The use of an opioid is common among people living with the human immunodeficiency virus (HIV; PLWH) and affects HIV outcomes harshly. The effect of the initiation of buprenorphine (BUP) on subsequent HIV viral loads was evaluated for a study. PLWH from the Johns Hopkins HIV Clinical Cohort was recognized who started BUP between 2002
